Background COVID-19 progression is associated with an increased risk of arterial and
venous thrombosis. Randomised trials have demonstrated that anticoagulants reduce the …

Background: COVID-19 (coronavirus disease 2019) is associated with heightened risks of
venous and arterial thrombosis and hospitalization due to respiratory failure. To assess …

Background COVID-19 is associated with a prothrombotic state. Current guidelines
recommend prophylactic anticoagulation upon hospitalization. Methods COVID-PREVENT …

Background COVID-19 is associated with both venous and arterial thrombotic complications.
While prophylactic anticoagulation is now widely recommended for hospitalized patients …

Background: Previous studies have demonstrated a high risk of arterial and venous
thromboembolic events as a consequence of direct viral damage to endothelial cells by …

Background The devastating Coronavirus disease (COVID-19) pandemic is associated with
a high prothrombotic state. It is unclear if the coagulation abnormalities occur because of the …

Background Patients hospitalised with COVID-19 are at risk for thrombotic events after
discharge; the role of extended thromboprophylaxis in this population is unknown. Methods …

Abstract Coronavirus disease 2019 (COVID-19) is associated with a high incidence of
venous and arterial thromboembolic events. The role of anticoagulation (AC) prior to …

2 Vascular Medicine 00 (0) most current guidelines. Both the International Society of
Thrombosis and Haemostasis (ISTH) and the European guidelines do not recommend …

Background Observational studies have suggested a higher risk of thrombotic events in
patients with coronavirus disease 2019 (COVID-19). Moreover, elevated D-dimer levels …